General surgery, Gastro and hepatology Flashcards
Appendicitis
acute inflammation of the vermiform appendix usually due to obstruction of the appendiceal lumen
Epidemiology of appendicitis
Most common cause of acute abdomen in children & adults
usually presents age 10-20yrs
Most common cause of acute abdomen
Appendicitis
Presentation of appendicitis
Abdominal pain (usually severe)
- starts periumbilical then migrates to RIF due to peritoneal inflammation
- worse on movement/coughing (i.e. pt lies still)
Nausea & vomiting
mild pyrexia
guarding, rebound tenderness, tenderness
Rovsing’s sign +ve: palpation of LIF leads to pain in RIF
Psoas sign +ve in retrocaecal appendix: pain on hip extension
Investigations for appendicitis
essentially a clinical diagnosis
FBC (↑ WCC, neutrophilia)
Pregnancy tests in females
CRP (↑)
USS or CT ± contrast
Management of appendicitis
appendectomy
-laparoscopic = 1st line
prophylactic Abx
analgesia
Complications of appendicitis
perforation (~20%) appendix abscess (after untreated perforation)
Aetiology of acute pancreatitis
GET SMASHED
G: gallstones
E: ethanol
T: trauma
S: steroids M: mumps A: autoimmune S: scorpion stings H: hypercalcaemia E: ERCP D: drugs e.g. mesalazine
Most common causes of acute pancreatitis
biliary pancreatitis (i.e. after gallstones)
alcohol induced
post ERCP, steroids, trauma
Presentation of acute pancreatitis
constant severe epigastric pain radiating to back -worse after meals -better when leaning forward N&V jaundice shock (hypotension, tachycardia) dyspnoea
Investigations for acute pancreatitis
often a clinical diagnosis
serum amylase (↑, often >3x upper limit of normal)
serum lipase (↑, often >3x upper limit of normal)
FBC (↑WCC)
U&Es
CRP
plain erect AXR
Glasgow score use
used for acute pancreatitis as a prognostic tool
alternatives include the RANSON score and the APACHE II score
Glasgow score for acute pancreatitis
Age >55 yrs WCC >15x10^9/L Urea >16 mmol/L glucose >10 mmol/L pO2 <8 kPa albumin <32 g/L Ca2+ <2 mmol/L LDH >600 units AST/ALT >200 units
Poor prognostic indicators for acute pancreatitis
age > 55 years hypocalcaemia hyperglycaemia hypoxia neutrophilia elevated LDH and AST
Management of acute pancreatitis
aggressive IV fluid therapy Nil by mouth NG tube feeding analgesia consider Abx if severe Early cholecystectomy/ERCP if related to gallstones
Chronic pancreatitis
caused by progressive inflammation & irreversible damage to the structure and exocrine/endocrine functions of the pancreas
Aetiology of chronic pancreatitis
~80% due to long term heavy chronic alcohol misuse
others: cystic fibrosis, heamachromatosis, ductal obstruction
Epidemiology of chronic pancreatitis
average pt is aged 40 yrs
4:1 male: female ratio
Presentation of chronic pancreatitis
epigastric pain -radiates to back -worse after meals (i.e. exacerbated by eating) -begins episodic then becomes constant weight loss pancreatic diabetes steatorrhoea -cramping/bloating Vit ADEK deficiency secondary to steatorrhoea
Investigations for chronic pancreatitis
AXR (pancreatic calcification)
CT (more sensitive for calcifications)
FBCs/U&Es/creatinine/LFTs/Ca2+/glucose
amylase (is normal)
Management of chronic pancreatitis
analgesia (often requires opioids) pancreatic enzyme replacement e.g. CREON abstinence from alcohol/smoking/drugs supplements such as Vit ADEK surgery if intractable pain
Diverticular disease
a set of colonic pathologies resulting from the abnormal out pouching of the colonic mucosa i.e. diverticula
Includes:
Diverticulosis (non-inflamed diverticuli)
Diverticulitis (inflammed/infected diverticuli)
Aetiology of diverticular disease
develop due to chronic elevations of intraluminal pressure e.g. due to constipation & the age related weakening of connective tissue
Risk factors diverticular disease
age >50 yrs
low fibre diet
obesity
Presentation of Diverticulosis
non specific abdo pain/discomfort
chronic constipation
bloating
Presentation of Diverticulitis
LLQ pain (NB pts of asian pts tend to have right sided diverticuli so present with LRQ pain) altered bowel habit (diarrhoea/constipation) localised tenderness on palpation
Presentation of diverticular haemorrhage
painless abrupt frank PR bleeding
Investigations for diverticular disease
if asymptomatic its usually and incidental finding
colonoscopy (diagnostic modality of choice) FBCs (↑ WCC)/CRP (↑) in diverticulitis U&Es barium enema CT cologram
Management of diverticular disease
↑ dietary fibre intake & ensure adequate fluid intake
analgesia
ABx for diverticulitis
surgery if perforation/uncontrolled sepsis/fistula
Complications of diverticular disease
fistulas perforation leading to peritonitis abscess formation haemorrhage intestinal obstruction
Hepatitis A (Hep A)
a viral hepatitis that is not associated with chronic liver disease
Key facts: most common form of acute viral hepatitis NOTIFIABLE disease in UK DOES NOT CAUSE CHRONIC DISEASE transmitted faeco-oral route
Hep A risk factors
travel to high risk areas e.g. tropics, male homosexuality + multiple partners, IVDU, personal contacts, pts with clotting disorders receiving factor VIII & IX
Presentation of Hep A
Flu like prodrome (fevers, malaise, myalgia)
RUQ pain
tender hepatomegaly
jaundice ± pruritus/pale stools/dark urine
Specific investigations for Hep A
anti-HAV IgG (↑)
-persist indefinitely=sign of previous infection/vaccination
anti-HAV IgM (↑)
-present in active infection
HAV RNA (+ve)
Investigations for acute viral hepatitis
ALT ↑ AST ↑ ALP ↑ gamma-GT ↑ bilirubin ↑
Management of Hep A
supportive management
avoid alcohol
avoid food handling
avoid unprotected intercourse
Hep A vaccination
not routinely given
consider if high risk pt e.g. MSM, IVDU, sewage workers, pts with chronic liver disease, pts with haemophilia
Hepatitis B (Hep B)
most common cause of hepatitis world wide
transmitted sexually, parenterally or perinatally
Acute presentation of Hep B
acute illness often sub clinical or presents as flu like illness (similar to Hep A)
Chronic presentation of Hep B
chronic disease (if HbsAg +ve for >6 months) fatigue, RUQ pain
Hep B investigations
LFTs (ALP/AST/ALT/bilirubin ↑)
HBsAg (+ve in acute disease)
HbeAg (+ve implies infectivity, i.e. recent infection)
HbcAg i.e. anti-HBc (+ve implies past infection, if only vaccinated -ve)
HbsAg i.e. anti-HBs (+ve if vaccinated or immunity)
Prevention of Hep B
vaccination
on routine childhood immunisation schedule
given at 2,3 and 4 months
Complications of Hep B
↑ risk of hepatocellular carcinoma (HCC)
chronic hepatitis
Hepatits C (Hep C)
transmitted parenterally e.g. IVDU/needlestick
↑ cases in UK
Presentation of Hep C
~80% initially asymptomatic initially, ~20% acute hepatitis (malaise, RUQ pain, tender hepatomegaly, jaundice)
Chronic infection (>6 months HCV RNA +ve) liver cirrhosis, arthralgia/arthritis, HCC, cryoglobulinaemia, membranoproliferazive glomerulonephritis
Investigations for Hep C
LFTs (↑ AST/ALT/ALP/GGT/bilirubin)
Hep C antibodies (+ve in immunocompetent pts)
HCV RNA (+ve)
Treatment for Hep C
Acute:
active monitoring or interferon to ↓ risk of chronic HCV
Chronic:
combination of protease inhibitors ± ribavirin
Viral hepatitis unable to vaccinated against
Hep C has no vaccine currently available
Hepatitis D (Hep D)
Virus requiring Hep B surface antigen to survive, so only develops in pts with HBsAg
i.e. as co-infection or superinfection with HBV
treated with interferon
Cirrhosis
a process characterised by diffuse fibrosis & conversion of normal liver architecture to structurally abnormal nodules known as regenerative nodules
the final stage of a variety of liver diseases
Aetiology of cirrhosis
Alcoholic liver disease
Hep B & Hep C infections
Non alcoholic fatty liver disease (NAFLD)
Others: haemochromatosis, primary biliary cirrhosis, primary sclerosis cholangitis
Risk factors for liver cirrhosis
excess alcohol consumption Hep B/C infection obesity IVDU unprotected sexual intercourse
Presentation of cirrhosis
often asymptomatic until decompensation
symptoms are generally vague
oedema, ascites, easy bruising, pruritus, jaundice, spider naevi, palamar erythema, leuchonychia, hepatomegaly,, nodular liver
Investigations for cirrhosis
LFTs -AST ↑ -ALT ↑ -GGT ↑ -ALP ↑ albumin ↓ FBC (↓Hb, thrombocytopenia) coagulation screen (↑ prothrombin time) transient elastography/acoustic radiation impulse imaging
Hep B/C serology, U&Es, ceruplasmin, urinary copper, ferritin, haemateninics
NB if AST > ALT indicates alcoholic liver disease, but ALT > AST suggests other causes
Classification of cirrhosis
Child-Pugh-Turcotte system
Management of cirrhosis
treat underlying cause
ensure adequate nutrition
stop alcohol intake
Zinc supplements (Zinc deficiency common)
Hep A/influenza/pneumococcal vaccinations
liver transplant (only curative measure)
Compensated vs decompensated cirrhosis
compensated = liver still able to function, generally minimal symptoms present
decompensated = liver not properly functioning leading to features such as jaundice, ascites etc
oesophageal varices
occur at the junction of the portal & systemic venous circulation usually in the distal oesophagus and/or proximal stomach
due to portal hypertension leading to dilation of the anastomosis of the 2 venous systems
Presentation of oesophageal varices
generally asymptomatic unless haemorrhaging haematemesis abdo pain malaena dysphagia/odynophagia pallor shock (hypotension, tachycardia, ↓ GCS)
Investigations for oesophageal varices
Endoscopy (OGD) -shows dilated veins -also therapeutic U&Es (↑ Urea) FBC, group & screen, LFTs U&Es (↑ Urea)
Management of oesophageal varices
Resuscitation, IV fluids, blood transfusions
Pre-endoscopy
- terlipressin or ocreotide
- prophylactic Abx
Endoscopy
-variceal band ligation (1st line)
uncontrolled haemorrhage
-sengstaken-blakemore tubes
Transjugular intrahepatice portosystemic shunt (TIPSS)
-last resort
Prophylaxis of oesophageal varices
Propanolol
endoscopic vatical band ligation + PPI cover
Portalhypertension
pathological elevation of portal venous pressure from obstruction of portal blood flow which may be pre-hepatic (portal vein thrombosis), intra-hepatic (cirrhosis) or post-hepatic (right sided HF)
clinically significant if hepatic venous pressure gradient ≥10mmHg
most commonly due to cirrhosis
Presentation of portal hypertension
dilated veins at portosystemic anastomosis
- paraumbilical veins & epigastric veins → caput medusae
- rectal veins → hemorrhoidal or anorectal varices
- veins of the gastric fundus & distal 1/3 of the esophagus → gastric/oesophageal varices
Congestive splenomegaly
Transudative ascites
signs of liver failure (jaundice, spider naevi, palmar erythema)
hyper dynamic circulation (bounding pulse, ↓BP, warm peripheries)
Investigations of portal hypertension
FBC, U&Es, LFTs, clotting
abdo USS (splenomegaly, portal vein dilation, cavernous transformation of portal vein)
abdo CT
Hepatic venous pressure gradient ( ≥10mmHg)
Management of portal hypertension
beta blockers ± nitrates (↓ pressure)
salt restriction & diuretics
Transjugular intrahepatice portosystemic shunt (TIPSS)\
treat underlying cause or liver transplant
complications of Transjugular intrahepatice portosystemic shunt (TIPSS)
exacerbation of hepatic encephalopathy is a common complication
Ascites
pathological collection of fluid in the peritoneal cavity
on clinical examination ~1500ml detectable
on USS can detect volumes ≤500ml
Aetiology of ascites
~75% = cirrhosis ~15% = malignancy e.g. meigs syndrome with ovarian cancer or GI tract malignancy
others: Heart failure, nephrotic syndrome
Presentation of ascites
progressive abdominal distension
abdominal discomfort (secondary to distension)
↑ weight
early satiety
dyspnoea
shifting dullness on percussion (+ve if ~1500ml fluid)
peripheral/generalised oedema
Investigations for ascites
serum-ascites albumin gradient (SAAG)
≥11g/L or ≥1.1g/dL = transudate (portal hypertension)
<11g/L or <1.1g/dL = exudate (hypoalbuniaemia)
FBC, U&Es, LFTs, clotting, TFTs
abdo USS or abdo MRI/CT (may show underlying cause)
ascitic tap
-SAAG
-cell count (neutrophils >250 indicates SBP)
-RBCs (<1000 = normal, ↑ indicates malignancy)
Serum-ascites albumin gradient (SAAG)
Helps to determine underlying cause but requires ascitic tap
≥11g/L or ≥1.1g/dL = transudate
indicates portal hypertension
i.e. liver failure/cirrhosis, liver malignancy, right sided HF, constrictive pericarditis etc
<11g/L or <1.1g/dL = exudate
indicates hyporlbuniameia
i.e. nephrotic syndrome, severe malnutrition (e.g. kwashiorkor), infections, pancreatitis
Management of ascites
restrict salt intake (especially in cirrhosis)
diuretics
-spironolactone (1st line in cirrhosis), monitor K+
± loop diuretics e.g. furosemide
therapeutic paracentesis -give Human albumin solution if removing large volumes TIPSS prophylactic ABx (to prevent SBP) -ciprofloxacin/norofloxacin
Spontaneous bacterial peritonitis (SBP)
a bacterial infection of ascitic fluid in the absence of any identifiable intra-abdominal source of infection
may be due to bacteria spreading across intestinal wall
Aetiology of Spontaneous bacterial peritonitis (SBP)
most commonly E. Coli
otherwise Klebsiella
Presentation of Spontaneous bacterial peritonitis (SBP)
fever ascites abdo pain naseau & vomiting constipation/diarrhoea
Investigations for Spontaneous bacterial peritonitis (SBP)
ascitic tap -neutrophil count >250 cells/mm3 -ascitic fluid culture FBC blood cultures
Management of Spontaneous bacterial peritonitis (SBP)
empirical Abx (generally IV)
-1st line: IV cefotaxime
-2nd line: IV ceftriaxone/ciprofloxacin
consider human albumin solution
Hepatorenal syndorme (HRS)
development of acute renal failure in pts with severe liver disease, commonly associated with Spontaneous bacterial peritonitis (SBP) or other infections
diagnosis of exclusion generally
can be in acute or chronic liver failure
Presentation of Hepatorenal syndorme (HRS)
jaundice
ascites
features of liver failure
peripheral oedema
Diagnostic criteria for Hepatorenal syndorme (HRS)
Diagnostic criteria:
- cirrhosis
- creatinine >133
- absence of shock/absence of hypovolaemia
- no recent treatment with nephrotoxic drugs
- absence of parenchymal renal disease
Types of Hepatorenal syndorme (HRS)
HRS type 1: rapidly progressing associated with precipitant event e.g. infection creatinine doubles to >221 in <2 weeks very poor prognosis
HRS type 2:
gradual decline of renal function
associated with Na+ retention & refractory ascites
Treatment of Hepatorenal syndorme (HRS)
splanchnic vasoconstrictors e.g. terlipressin
human album solution
treat precipitating infection
TIPSS
Hepatic encephalopathy
a spectrum of neuropsychiatric abnormalities cause by acute/chronic hepatic insufficiency generally related to excess ammonia & glutamine absorption in the brain due to portosystemic shunting
precipitating events for hepatic encephalopathy
transjugular intrahepatic portosystemic shunting (TIPSS) infections e.g. SBP renal failure constipation GI bleed
Presentation of hepatic encephalopathy
confusion & altered level of consciousness
fatigue, lethargy, apathy, irritability
disorientation, memory loss, sleep impairment
socially aberrant behaviour
slurred speech, muscle rigidity, constructional apraxia
asterix (liver flap)
arrhythmic negative myoclonus
Grading of hepatic encephalopathy
I: irritability & sleep disturbances
II: confusion & inappropriate behaviour
III: incoherent, restless, somnolent but rousable, amnesia, disorientation
IV: coma
Management of hepatic encephalopathy
reducing gut nitrogen load
1st line : lactulose + rifamixin (sedentary prophylaxis)
2nd line enemas
Prophylaxis of hepatic encephalopathy
Rifamixin reduces recurrences
Hepatopulmonary syndrome
secondary to portal hypertension
triad of hepatic dysfunction, hyperaemia, extreme vasodilation of intrapulmonary vasculature
presents with dyspnoea, platypnoea (SOB better when lying flat), orthodeoxia (↓sats when going from lying to standing)
resolves after liver transplant
Portopulmonary hypertension
unexplained pulmonary hypertension in association with portal hypertension
often asymptomatic
requires echo & right heart catheterisation
treatment is liver transplant
Hepatocellular carcinoma (HCC)
a malignant usually solitary tumour of the liver often seen in pts with pre-existing cirrhosis or chronic hepatitis
~90% of all liver cancers (most common primary liver tumour)
Aetiology of Hepatocellular carcinoma (HCC)
chronic Hepatitis B or C infections (most common cause)
alcoholic liver disease
others: haemochromatosis, primary biliary cirrhosis
Epidemiology of Hepatocellular carcinoma (HCC)
more common in men (~4x)
usually seen age 65-70 yrs
Presentation of Hepatocellular carcinoma (HCC)
usually presents with symptoms of cirrhosis/liver failure
pruritus splenomegaly & hepatomegaly weight loss oesophageal varices jaundice hepatic encephalopathy ascties RUQ pain/tenderness spider naevi caput medusa flapping tremor
Screening for Hepatocellular carcinoma (HCC)
for pts at risk of HCC e.g. HBV/HCV or alcohol related cirrhosis
USS every 6-12 months ± Alpha fetoprotein (AFP)
Investigations for Hepatocellular carcinoma (HCC)
Serum AFP (↑) LFTs, FBC, Clotting liver USS (best initial investigation) contrast enhanced CT/MRI abdo liver biopsy
Tumour marker for Hepatocellular carcinoma (HCC)
Serum Alpha fetoprotein (AFP)
Management of Hepatocellular carcinoma (HCC)
tumour resection
-requires good liver function
liver transplant
-only very few pts suitable
Ablative therapy e.g. radio frequency ablation
-treatment fo choice in early stages
systematic chemotherapy
Chemoembolisation
-requires good liver function & no extra hepatic spread vascular invasion
Non alcoholic fatty liver disease (NAFLD)
Fatty liver disease developing in patients that do not consume alcohol in amounts considered harmful
most common cause of chronic liver disease in the developed world
Risk factors for Non alcoholic fatty liver disease (NAFLD)
obesity T2DM hyperlipidaemia jejunoileal bypass sudden weight loss/starvation metabolic syndrome HTN total parenteral nutrition
Presentation of Non alcoholic fatty liver disease (NAFLD)
often asymptomatic hepatomegaly obesity fatigue features of cirrhosis
Investigations for Non alcoholic fatty liver disease (NAFLD)
LFTs (all ↑, ALT > AST, i.e. AST:ALT ratio <1 )
-if AST:ALT ratio reverses (>1) may mean progression to cirrhosis
fasting lipids (↑)
liver USS (hyperechogenic)
Liver biopsy (only definitive test)
FBC, viral serology, iron studies, ceruloplasmin
Management of Non alcoholic fatty liver disease (NAFLD)
lifestyle changes (diet &exercise)
weight loss
monitoring of disease
Alcoholic related fatty liver disease
similar to Non alcoholic fatty liver disease (NAFLD) but in pts consuming harmful amounts of alcohol
Investigations
- gamma-GT (↑↑)
- AST:ALT ratio >2 (>3 almost exclusively sent in alcoholic liver disease)
Managed with drinking cessation
glucocorticoids are used in acute episodes of alcoholic hepatitis
Wilson’s disease (hepatolenticular degeneration)
autosomal recessive disease of copper accumulation & copper toxicity caused by mutations of ATP7b gene (part of biliary copper pathway)
i.e. disease of hepatic copper deposition
Genetics of wilson’s disease
autosomal recessive
mutations of ATP7b gene
Epidemiology of Wilson’s disease
RARE condition
onset usually age 10-25yrs
usually goes undiagnosed until combination of hepatitis, dementia & Parkinsonism causes clinical suspicion
Presentation of Wilson’s disease
Hepatic features:
-hepatitis, cirrhosis, hepatosplenomegaly, jaundice, portal hypertension, ascites
Neurological features
-basal ganglia degeneration, dysarthria, dystonia, parkinsonism, drooling, ataxia, wing beating tremor, asymmetric tremor (most common early neurological feature)
Psychiatric features:
-depression, behavioural change, irritability, cognitive impairment, psychosis
ophthalmic features:
-Kayser-Fleischer rings (green-brown rings in periphery of iris due to copper deposition)
Renal tubular acidosis (Fanconi syndrome)
blue nails
infertility
Investigations for Wilson’s disease
slit lamp examination
-for Kayser-Fleischer rings
Serum caeruloplasmin (↓) Total serum copper (↓) LFTs (deranged) urinary copper excretion (↑) Liver biopsy (↑parenchymal copper concentration)
Management of Wilson’s disease
monitor LFTs, coagulation, FBCs
1st line: Penicillamine (copper chelation)
-trientine hydrochloride (slowly becoming 1st line)
usually combined with Zinc (↓ copper absorption)
Haemochromatosis
multisystem disorder of iron absorption & metabolism resulting in iron accumulation
autosomal recessive mutation of the HFE gene
most common genetic disorder in white people
genetics of Haemochromatosis
autosomal recessive
mutation of the HFE gene
Presentation of Haemochromatosis
Early features:
-fatigue, lethargy, arthralgia, erectile dysfunction
Later features:
- liver (abdo pain, jaundice, cirrhosis)
- bronze pigmentation of skin
- diabetes mellitus
- cardiac failure (dilated cardiomyopathy)
- hypogonadism
- arthritis (especially of hands)
Investigations for Haemochromatosis
Joint X-rays (chonedrocalcinosis)
Ferritin (↑) serum iron (↑) Total iron binding capacity (TIBC) (↑) transferrin saturation (↑) ->55% in men, >50% in women
LFTs
-↑AST, ↑ALT
MRI (to measure liver iron content)
echocardiogram (dilated cardiomyopathy)
Genetic testing
-for 1st degree relatives of pt with confirmed disease/confirmed iron overload
Management of Haemochromatosis
1st line: phlebotomy/venesection
2nd line: desferrioxamine
Liver transplant in end stage liver disease
Autoimmune hepatitis
condition of unknown origin generally seen in young females, associated with other autoimmune conditions
presents with signs of chronic.acute liver disease & amenorrhoea
Investigations include LFTs (deranged, ↑ ↑ALT), serum antibodies, IgG (↑) and liver biopsy (key)
Managed with steroids & immunosuppressants e.g. azathioprine
Acute liver failure
rapid onset hepatocellular dysfunction
usually due to paracetamol overdose, acute fatty liver disease fo pregnancy, viral hepatitis (Hep A/B) or alcohol
presents with jaundice, coagulopathy (↑ prothrombin time), hypoalbuminaemia, hepatic encephalopathy and hepatorenal syndrome
Mangement is early liver transplant
Gallstones (cholelithiasis)
the presence of solid concretions in the gall bladder which may pass into the bile duct and cause obstruction
very common condition
in developed countries 90% of gallstones are made of cholesterol
Risk factors for gallstones
↑age FH of gallstones sudden weight loss diabetes oral contraception pregnancy female gender
Presentation of gallstones
mostly asymptomatic
biliary colic:
colicky RUQ pain
-worse after easting, worse after fatty food
-pain may radiate to R shoulder/intrascapular region
N&V
bloating
Investigations for gallstones
USS of RUQ (demonstrates stones)
-if -ve but high index of suspicion then repeat
ERCP or CT
Management of gallstones
expectant management if asymptomatic
ERCP (to remove stones)
elective laparoscopic cholecystectomy
Acute cholecystitis
acute gallbladder inflammation
one of the major complications of gallstones, developing in ~10%of symptomatic pts with gallstones
usually due too complete cystic duct obstruction (~90% of cases)
Risk factors for Acute cholecystitis
gallstones female gender ↑age obesity pregnancy Crohns disease hyperlipidaemia
Presentation of Acute cholecystitis
RUQ pain
- radiating to R shoulder/epigastric region
- severe & prolonged pain (>6h)
- worse after eating
Fever, malaise, N&V
Murphys sign +ve
- press on RUQ and ask pt to breath in
- +ve if elicits pain leading to arrestor inspiration
- only +ve if same manoeuvre in LUQ doesn’t cause pain
Investigations for Acute cholecystitis
USS (1st line investigation)
-shows thickened gallbladder walls, distended gallbladder and possibly gallstones
FBC (↑ WCC)
CRP (↑)
LFTs (usually normal)
consider MRI/CT/HIDA if USS inconclusive
Management of Acute cholecystitis
IV Abx analgesia e.g. morphine early laparoscopic cholecystectomy -within 1 week of diagnosis -gold standard
Acute/ascending cholangitis
an infection of the biliary tree typically secondary to biliary obstruction & stasis secondary to gallstones
may also be caused by malignancy affecting the biliary tree
causative organisms is usually E. Coli
Presentation of Acute/ascending cholangitis
Charcots triad:
- RUQ pain (maybe poorly localised abdo pain in elderly)
- Fever
- Jaundice
Raynauds pentad
- RUQ pain (maybe poorly localised abdo pain in elderly)
- Fever
- Jaundice
- hypotension (septic shock)
- confusion
Investigations for Acute/ascending cholangitis
FBC (↑WCC) ESR/CRP (↑) LFTs (↑bilirubin, ↑AST, ↑ALT, ↑ALP, ↑GGT) U&Es (↑creatinine, ↑urea) blood cultures amylase (may be ↑) USS abdo (dilated bile ducts ±gallstones) ERCP/CT scan
management of Acute/ascending cholangitis
IV ABx & IV fluids
analgesia
endoscopic retrograde cholangipancreatography (ERCP)
-after 24-48h to relieve any obstruction
Primary biliary cholangitis / Primary biliary cirrhosis (PBC)
chronic disease of the small intrahepatic bile ducts of autoimmune origin thats is characterised by destruction of interlobular bile ducts due to chronic inflammation
Conditions associated with Primary biliary cholangitis (PBC)
Sjogrens syndrome (up to 80% of pts)
Rheumatoid arthritis
systemic sclerosis
thyroid disease
Presentation of Primary biliary cholangitis (PBC)
initially asymptomatic fatigue, pruritus cholestatic jaundice, dark urine, pale stools hepatomegaly RUQ discomfort hyperpigmentation, xanthelasma cirrhosis (in advanced disease)
Investigations for Primary biliary cholangitis (PBC)
LFTs (↑ gamma-GT, ↑ALP, ↑bilirubin) ESR (↑) IgM (↑) anti-mitochondrial antibodies (AMA) M2 (+ve) abdo USS MRI cholangiopancreatography (MRCP)